...
首页> 外文期刊>Frontiers in Immunology >Human Immunodeficiency Virus Type-1 Elite Controllers Maintain Low Co-Expression of Inhibitory Receptors on CD4+ T Cells
【24h】

Human Immunodeficiency Virus Type-1 Elite Controllers Maintain Low Co-Expression of Inhibitory Receptors on CD4+ T Cells

机译:人类免疫缺陷病毒1型精英控制器维持CD4 + T细胞上抑制受体的低共表达

获取原文
           

摘要

Human immunodeficiency virus type-1 (HIV-1) elite controllers (ELCs) represent a unique population that control viral replication in the absence of antiretroviral therapy (cART). It is well established that expression of multiple inhibitory receptors on CD8+ T cells is associated with HIV-1 disease progression. However, whether reduced co-expression of inhibitory receptors on CD4+ T cells is linked to natural viral control and slow HIV-1 disease progression remains undefined. Here, we report on the expression pattern of numerous measurable inhibitory receptors, associated with T cell exhaustion (programmed cell death-1, CTLA-4, and TIGIT), on different CD4+ T cell memory populations in ELCs and HIV-infected subjects with or without long-term cART. We found that the co-expression pattern of inhibitory receptors was significantly reduced in ELCs compared with HIV-1 cART-treated and viremic subjects, and similar to healthy controls. Markers associated with T cell exhaustion varied among different memory CD4+ T cell subsets and highest levels were found mainly on transitional memory T cells. CD4+ T cells co-expressing all inhibitory markers were positively correlated to T cell activation (CD38+ HLA-DR+) as well as the transcription factors Helios and FoxP3. Finally, clinical parameters such as CD4 count, HIV-1 viral load, and the CD4/CD8 ratio all showed significant associations with CD4+ T cell exhaustion. We demonstrate that ELCs are able to maintain lower levels of CD4+ T cell exhaustion despite years of ongoing viral replication compared with successfully cART-treated subjects. Our findings suggest that ELCs harbor a “healthy” state of inhibitory receptor expression on CD4+ T cells that might play part in maintenance of their control status.
机译:人类1型免疫缺陷病毒(HIV-1)精英控制者(ELCs)代表了一个独特的群体,可以在没有抗逆转录病毒疗法(cART)的情况下控制病毒的复制。众所周知,CD8 + T细胞上多种抑制性受体的表达与HIV-1疾病的进展有关。但是,尚不确定CD4 + T细胞上抑制受体的共表达与自然病毒控制和HIV-1疾病进展缓慢有关。在这里,我们报道了在ELCs和HIV感染者的不同CD4 + T细胞记忆人群中,与T细胞衰竭(程序性细胞死亡1,CTLA-4和TIGIT)相关的许多可测量抑制受体的表达模式。没有长期的购物车。我们发现与HIV-1 cART治疗和病毒血症受试者相比,ELCs中抑制性受体的共表达模式显着降低,并且与健康对照组相似。与T细胞衰竭相关的标志物在不同的记忆CD4 + T细胞子集中有所不同,并且最高水平主要在过渡记忆T细胞上发现。共表达所有抑制标记的CD4 + T细胞与T细胞活化(CD38 + HLA-DR +)以及转录因子Helios和FoxP3正相关。最后,诸如CD4计数,HIV-1病毒载量和CD4 / CD8比之类的临床参数均显示与CD4 + T细胞衰竭有关。我们证明,与成功进行cART治疗的受试者相比,尽管多年持续进行病毒复制,ELC仍能够维持较低水平的CD4 + T细胞衰竭。我们的发现表明,ELC在CD4 + T细胞上具有抑制受体表达的“健康”状态,这可能在维持其控制状态中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号